Mindfulness-based Psychotherapy and Social Support Intervention for Drug-resistant Epilepsy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Epilepsy
- Sponsor
- Chinese University of Hong Kong
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Change in quality of life (Quality of Life in Epilepsy Inventory-31-P Total Score) from baseline to post-intervention
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
Psychological problems are prevalent among patients with drug-resistant epilepsy. The bi-directional interaction between psychological well-being and seizure have been recognized in recent years. Reduction of psychological stress has the potential to improve seizure manifestation.
The present study uses an assessor-blinded prospective randomized controlled trial to evaluate the efficacy of a mindfulness-based psychotherapy and an attentional-placebo social support on improving psychological well-being, seizure control and cognitive performance among adult patients with drug-resistant epilepsy.
Investigators
Venus Tang
Dr
Chinese University of Hong Kong
Eligibility Criteria
Inclusion Criteria
- •a diagnosis of epilepsy
- •over 18 years of age
- •resistant to pharmacological treatment according to the ILAE guideline
- •no previous history of neurosurgery
- •adequate level of reading and understanding ability to fill in questionnaires
- •capable to communicate with the investigator with considerable expressive capacity
- •patients who agree to cooperate with the study procedures required by the protocol
- •patients who understand the nature of the study, agree to participate and sign the informed consent form
Exclusion Criteria
- •with primary diagnosis of substance use disorder, mood disorder, bipolar affective disorder, psychosis, or organic mental disorder
- •with diagnosis of learning disability or mental retardation
Outcomes
Primary Outcomes
Change in quality of life (Quality of Life in Epilepsy Inventory-31-P Total Score) from baseline to post-intervention
Time Frame: Baseline, 4-week post-intervention